| Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden P Peneder, AM Stütz, D Surdez, M Krumbholz, S Semper, M Chicard, ... Nature communications 12 (1), 3230, 2021 | 98 | 2021 |
| Proteomics and transcriptomics of peripheral nerve tissue and cells unravel new aspects of the human Schwann cell repair phenotype T Weiss, S Taschner‐Mandl, A Bileck, A Slany, F Kromp, F Rifatbegovic, ... Glia 64 (12), 2133-2153, 2016 | 82 | 2016 |
| RelB regulates human dendritic cell subset development by promoting monocyte intermediates B Platzer, A Jörgl, S Taschner, B Höcher, H Strobl Blood 104 (12), 3655-3663, 2004 | 78 | 2004 |
| GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity S Heitzeneder, KR Bosse, Z Zhu, D Zhelev, RG Majzner, MT Radosevich, ... Cancer Cell 40 (1), 53-69. e9, 2022 | 76 | 2022 |
| Differential involvement of PU. 1 and Id2 downstream of TGF-β1 during Langerhans-cell commitment LX Heinz, B Platzer, PM Reisner, A Jörgl, S Taschner, F Göbel, ... Blood 107 (4), 1445-1453, 2006 | 73 | 2006 |
| Down-regulation of RXRα expression is essential for neutrophil development from granulocyte/monocyte progenitors S Taschner, C Koesters, B Platzer, A Jörgl, W Ellmeier, T Benesch, ... Blood 109 (3), 971-979, 2007 | 65 | 2007 |
| Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome SA Hartlieb, L Sieverling, M Nadler-Holly, M Ziehm, UH Toprak, ... Nature Communications 12 (1), 1269, 2021 | 57 | 2021 |
| Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma D Bogen, JS Wei, DO Azorsa, P Ormanoglu, E Buehler, R Guha, JM Keller, ... Oncotarget 6 (34), 35247, 2015 | 57 | 2015 |
| Assessment of pre-analytical sample handling conditions for comprehensive liquid biopsy analysis T Gerber, S Taschner-Mandl, L Saloberger-Sindhöringer, N Popitsch, ... The Journal of Molecular Diagnostics 22 (8), 1070-1086, 2020 | 54 | 2020 |
| Neuroblastoma and the epigenome IS Fetahu, S Taschner-Mandl Cancer and Metastasis Reviews 40 (1), 173-189, 2021 | 52 | 2021 |
| An annotated fluorescence image dataset for training nuclear segmentation methods F Kromp, E Bozsaky, F Rifatbegovic, L Fischer, M Ambros, M Berneder, ... Scientific Data 7 (1), 262, 2020 | 49 | 2020 |
| Schwann cell plasticity regulates neuroblastic tumor cell differentiation via epidermal growth factor-like protein 8 T Weiss, S Taschner-Mandl, L Janker, A Bileck, F Rifatbegovic, F Kromp, ... Nature communications 12 (1), 1624, 2021 | 48 | 2021 |
| Evaluation of deep learning architectures for complex immunofluorescence nuclear image segmentation F Kromp, L Fischer, E Bozsaky, IM Ambros, W Dörr, K Beiske, PF Ambros, ... IEEE Transactions on Medical Imaging 40 (7), 1934-1949, 2021 | 45 | 2021 |
| Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic cell differentiation F Göbel, S Taschner, J Jurkin, S Konradi, C Vaculik, S Richter, ... Blood, The Journal of the American Society of Hematology 114 (18), 3813-3821, 2009 | 44 | 2009 |
| Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB A Jörgl, B Platzer, S Taschner, LX Heinz, B Höcher, PM Reisner, ... Blood 109 (1), 185-193, 2007 | 44 | 2007 |
| Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence S Taschner-Mandl, M Schwarz, J Blaha, M Kauer, F Kromp, N Frank, ... Oncotarget 7 (3), 3571, 2016 | 42 | 2016 |
| The evolutionary dynamics of extrachromosomal DNA in human cancers JT Lange, JC Rose, CY Chen, Y Pichugin, L Xie, J Tang, KL Hung, ... Nature genetics 54 (10), 1527-1533, 2022 | 41 | 2022 |
| Selection of peptide entry motifs by bacterial surface display S Taschner, A Meinke, A GABAIN, AP Boyd Biochemical Journal 367 (2), 393-402, 2002 | 37 | 2002 |
| Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1) A Bellini, U Pötschger, V Bernard, E Lapouble, S Baulande, PF Ambros, ... Journal of Clinical Oncology 39 (30), 3377, 2021 | 35 | 2021 |
| Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression F Rifatbegovic, C Frech, MR Abbasi, S Taschner‐Mandl, T Weiss, ... International Journal of Cancer 142 (2), 297-307, 2018 | 29 | 2018 |
